YAPHARM
Timeline
17 events since 2020Filings
Financial
Establishments
Address
Other
2020202220242026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBabbreviated format · 31 days late
Registered in the Peppol Directory Reachable for e-invoices through 0208:0752712377
2025
Back to profit net €41,299 The net result is €41,299, after 2 loss-making years.
Liquidity more than 7 times current ratio 2.48 The current ratio rises from 0.32 to 2.48. Short-term debt falls from €298,247 to €47,239.
Equity above €150,000 equity €158,159 ▲35.3% Equity rises from €116,860 to €158,159.
Annual accounts 2024 filed PDFfull format · 7 days before the deadline
2024
Weakest financial year net -€5,919 The net result drops to -€5,919, the lowest from 2021 to 2025. It recovers the following year.
Registered office moved from Dilbeek to UccleNew registered office: Gabriellestraat, 44-1180 Ukkel · Previous registered office: Hoogveldlaan 38 bus 201-1700 Dilbeek · Yassine Aikar holds all the shares · General meeting of 29-10-20243 points ▸
- General meeting, 29-10-2024
- Yassine Aikar holds all the shares
- Registered-office move, Gabriellestraat, 44-1180 Ukkel
- The deed holds 1 more point.
Annual accounts 2023 filed PDFmicro format · 30 days late
2023
Annual accounts 2022 filed PDFmicro format · 70 days late
2022
Highest result from 2021 to 2025 net €91,373 ▲57.4% The operating result of €116,267 and the net result of €91,373 are both a record.
Equity above €100,000 equity €126,916 ▲179% With a profit in every financial year since 2021, equity grows to €126,916.
Annual accounts 2021 filed PDFmicro format · 61 days late
2020
Publication in the Belgian Official Gazette PDF
Publication in the Belgian Official Gazette PDF
IncorporationFounding capital of €2,000, 100 shares · Founder: AIKAR Yassine (comparant) · Appointment: AIKAR Yassine (director) · published on 20-08-20205 points ▸
- Founder, AIKAR Yassine (comparant)
- Founding capital, €2,000, 100 shares
- Registered office clause, Hoofveldlaan 38, bus 201, 1700 Dilbeek
- Board rule, 1
- Director appointment, AIKAR Yassine
- The deed holds 4 more points.
First establishment
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
YAPHARM was incorporated on 18 August 2020 as a private limited company by one natural person, with a starting capital of €2,000.12 The registered office was moved to Uccle in 2024.3 AIKAR Yassine is director of the company, appointed by deed of 20-08-2020.2 Total assets rose from €90,165 in 2021 to €436,227 in 2025.4